Brazilian Health Minister Alexandre Padilha said U.S. restrictions under the Magnitsky Act do not prevent partnerships between Brazilian institutions and U.S. companies or universities [1].
This shift in strategy highlights Brazil's attempt to maintain critical technological and scientific cooperation while navigating diplomatic tensions with the U.S. government. By pivoting the location of these collaborations, Brazil aims to bypass political barriers and ensure the continued flow of innovation into its public health sector.
Speaking during an interview with CNN Brasil's "Bastidores" program, Padilha said the impact of sanctions targeting Brazilian authorities [1]. He said that the Brazilian government is actively working to bring American firms into the country to facilitate joint ventures and research initiatives [1, 2].
Padilha said that the current political climate in the U.S. necessitates a change in how the two nations interact. He said that the focus has shifted toward attracting private sector investment and academic expertise directly to Brazilian soil [1, 2].
"Trump não nos quer nos EUA, trazemos as empresas para cá," Padilha said [1].
The minister said that the private sector and academic institutions in the U.S. often operate independently of the specific diplomatic restrictions imposed by the U.S. government [1]. This distinction allows Brazil to pursue scientific advancement even while certain officials remain under the scrutiny of the Magnitsky Act [1].
By hosting these entities within its own borders, Brazil seeks to secure the intellectual property, and technical support required for its health infrastructure without relying on the hospitality of the U.S. administration [1, 2].
“"Trump não nos quer nos EUA, trazemos as empresas para cá,"”
The Brazilian government is implementing a 'de-risking' strategy by decoupling its scientific and corporate needs from the diplomatic relationship between the two heads of state. By inviting US universities and firms to operate within Brazil, the administration seeks to insulate its public health and technological progress from the volatility of US sanctions and political shifts.
